Yousif Capital Management LLC Sells 4,000 Shares of Relx Plc (NYSE:RELX)

Yousif Capital Management LLC lowered its position in shares of Relx Plc (NYSE:RELXFree Report) by 15.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,961 shares of the technology company’s stock after selling 4,000 shares during the quarter. Yousif Capital Management LLC’s holdings in Relx were worth $997,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. CENTRAL TRUST Co raised its position in shares of Relx by 1,290.2% during the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after acquiring an additional 529 shares during the last quarter. Versant Capital Management Inc bought a new stake in Relx in the fourth quarter valued at about $31,000. Private Trust Co. NA increased its holdings in Relx by 119.9% in the third quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock valued at $49,000 after purchasing an additional 566 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in Relx in the third quarter valued at about $125,000. Finally, Whittier Trust Co. of Nevada Inc. grew its stake in Relx by 33.9% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 3,952 shares of the technology company’s stock valued at $188,000 after acquiring an additional 1,000 shares during the period. Institutional investors own 15.02% of the company’s stock.

Relx Stock Down 1.5 %

NYSE:RELX opened at $51.14 on Friday. Relx Plc has a 1 year low of $40.25 and a 1 year high of $51.99. The company has a debt-to-equity ratio of 1.63, a current ratio of 0.48 and a quick ratio of 0.42. The stock has a 50-day moving average price of $47.74 and a two-hundred day moving average price of $47.13.

Analyst Upgrades and Downgrades

RELX has been the subject of a number of research analyst reports. Redburn Atlantic initiated coverage on Relx in a research note on Wednesday, January 8th. They issued a “buy” rating for the company. StockNews.com raised Relx from a “hold” rating to a “buy” rating in a research note on Friday.

Get Our Latest Report on Relx

About Relx

(Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

See Also

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.